For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Kathleen Wilson, MPH
Advertisement
Articles by Kathleen Wilson, MPH
Advertisement
Latest Updated Articles
- Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic Arthritis
Published: September 21st 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Estradiol-Containing MHT May Impact Alzheimer Disease-Related Biomarkers in Postmenopausal Women
2
Axatilimab: A New Frontier for Steroid-Refractory Chronic GVHD
3
CHEST 2025: Exploring the Link Between GLP-1 Receptor Agonists, Type 2 Diabetes, and Asthma Risk
4
World Standards Week 2025: Advancing Quality and Patient Safety Standards to Shape Pharmacy Practice and Innovation
5
